[1] Punjabi NM. The epidemiology of adult obstructive sleep apnea[J]. Proc Am Thorac Soc, 2008, 5(2): 136-143. [2] Badran M, Ayas N, Laher I. Insights into obstructive sleep apnea research[J]. Sleep Med, 2014, 15(5): 485-495. [3] Ramar K, Caples SM. Cardiovascular consequences of obese and nonobese obstructive sleep apnea[J]. Med Clin North Am, 2010, 94(3): 465-478. [4] Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea[J]. Nat Rev Cardiol, 2010, 7(12): 677-685. [5] Maeder MT, Schoch OD, Rickli H. A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease[J]. Vasc Health Risk Manag, 2016, 12: 85-103. [6] Buchner NJ, Quack I, Woznowski M, et al. Microvascular endothelial dysfunction in obstructive sleep apnea is caused by oxidative stress and improved by continuous positive airway pressure therapy[J]. Respiration, 2011, 82(5): 409-417. [7] 李 浩, 张苏丽, 杨 艳,等. 利用微血管环技术检测肠系膜动脉三级分支张力的方法[J]. 中国应用生理学杂志, 2014, 30(3): 214-217. [8] Jafari B, Mohsenin V. Chitinase-3-like protein-1 (YKL-40) as a marker of endothelial dysfunction in obstructive sleep apnea[J]. Sleep Med, 2016, 25: 87-92. [9] Chen L, Guo QH, Chang Y, et al. Tanshinone IIA ameliorated endothelial dysfunction in rats with chronic intermittent hypoxia[J]. Cardiovasc Pathol, 2017, 31: 47-53. [10]Duchna HW, Guilleminault C, Stoohs RA, et al. Vascular reactivity in obstructive sleep apnea syndrome[J]. Am J Respir Crit Care Med, 2000, 161(1): 187-191. [11]Kato M, Roberts-Thomson P, Phillips BG, et al. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea[J]. Circulation, 2000, 102(21): 2607-2610. [12]明 佳, 徐 竞, 李 涛, 等. 连接蛋白40/43调节大鼠血管平滑肌细胞内钙离子浓度与肠系膜上动脉收缩反应性的研究[J]. 中华烧伤杂志, 2009, 25(1): 31-35. [13]Ayas NT, Taylor CM, Laher I. Cardiovascular consequences of obstructive sleep apnea[J]. Curr Opin Cardiol, 2016, 31(6): 599-605. [14]Krause BJ, del Rio R, Moya EA, et al. Arginase-endothelial nitric oxide synthase imbalance contributes to endothelial dysfunction during chronic intermittent hypoxia[J]. J Hypertens, 2015, 33(3): 515-524. [15]Delaey C, Boussery K, van de Voorde J. Contractility studies on isolated bovine choroidal small arteries: determination of the active and passive wall tension-internal circumference relation[J]. Exp Eye Res, 2002, 75(3): 243-248. [16]Saletu M, Sauter C, Lalouschek W, et al. Is excessive daytime sleepiness a predictor of carotid atherosclerosis in sleep apnea[J]? Atherosclerosis, 2008, 196(2): 810-816. [17]Guo QH, Tian YL, Wang Z, et al. Endothelin receptors in augmented vasoconstrictor responses to endothelin-1 in chronic intermittent hypoxia[J]. Clin Exp Pharmacol Physiol, 2013, 40(7): 449-457. [18]Wang JW, Li AY, Guo QH, et al. Endothelin-1 and ET receptors impair left ventricular function by mediated coronary arteries dysfunction in chronic intermittent hypoxia rats[J]. Physiol Rep, 2017, 5(1): e13050. [19]杨玉萍, 李瑞旻, 李佳佳, 等. 阻塞性睡眠呼吸暂停低通气综合征合并高血压中医分型与睡眠参数的相关性研究[J]. 江西中医药, 2018, 49(3): 38-41. [20]Grossini E, Gramaglia C, Farruggio S, et al. Asenapine increases nitric oxide release and protects porcine coronary artery endothelial cells against peroxidation[J]. Vascul Pharmacol, 2014, 60(3): 127-141. [21]Umans JG, Levi R. Nitric oxide in the regulation of blood flow and arterial pressure[J]. Annu Rev Physiol, 1995, 57: 771-790. [22]赵艳霞, 李玉红, 王亚平, 等. 高脂饮食对慢性低氧大鼠肺组织 eNOS /NO 的影响[J]. 中国应用生理学杂志, 2014, 30(4): 377-380. [23]Lavie L. Oxidative stress in obstructive sleep apnea and intermittent hypoxia--revisited--the bad ugly and good: implications to the heart and brain[J]. Sleep Med Rev, 2015, 20: 27-45. [24]Yu FC, Yuan CX, Tong JY, et al. Protective effect of sphingosine-1-phosphate for chronic intermittent hypoxia-induced endothelial cell injury[J]. Biochem Biophys Res Commun, 2018, 498(4): 1016-1021. [25]Hernandez-Guerra M, De Ganzo ZA, Gonzalez-Mendez Y, et al. Chronic intermittent hypoxia aggravates intrahepatic endothelial dysfunction in cirrhotic rats[J]. Hepatology, 2013, 57(4): 1564-1574. [26]Montanez R, Rodriguez-Caso C, Sanchez-Jimenez F, et al. In silico analysis of arginine catabolism as a source of nitric oxide or polyamines in endothelial cells[J]. Amino Acids, 2008, 34(2): 223-229. [27]Santhanam L, Christianson DW, Nyhan D, et al. Arginase and vascular aging[J]. J Appl Physiol (1985), 2008, 105(5): 1632-1642. [28]Krause BJ, Carrasco-Wong I, Caniuguir A, et al. Endothelial eNOS/arginase imbalance contributes to vascular dysfunction in IUGR umbilical and placental vessels[J]. Placenta, 2013, 34(1): 20-28. [29]Demougeot C, Prigent-Tessier A, Marie C, et al. Arginase inhibition reduces endothelial dysfunction and blood pressure rising in spontaneously hypertensive rats[J]. J Hypertens, 2005, 23(5): 971-978. |